ATI-1777

· Aclaris Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ATI-1777, covering 2023-09-28 to 2024-10-26. Get the full timeline:

Most recent: Clinical Trial Update: Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis [Phase 2]